CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,900 | $490.98 | $1.4M | 130 |
| 2025-12-12 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −4,000 | 18,000 | ||
| 2025-12-11 | MALCOLM JAN Director | Sale 10b5-1 | −50 | $482.98 | $24K | 470 |
| 2025-12-11 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise 10b5-1 | +11,000 | $146.03 | $1.6M | 47,781 |
| 2025-12-11 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −560 | $482.22 | $270K | 47,221 |
| 2025-12-11 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −900 | $483.25 | $435K | 46,321 |
| 2025-12-11 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −5,220 | $484.31 | $2.5M | 41,101 |
| 2025-12-11 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,804 | $485.22 | $1.4M | 38,297 |
| 2025-12-11 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,116 | $486.36 | $543K | 37,181 |
| 2025-12-11 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −400 | $487.37 | $195K | 36,781 |
| 2025-12-11 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise · Stock Option 10b5-1 | −11,000 | 20,250 | ||
| 2025-12-11 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-12-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,500 | $483.12 | $725K | 2,630 |
| 2025-12-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,976 | $484.30 | $957K | 654 |
| 2025-12-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −524 | $485.14 | $254K | 130 |
| 2025-12-11 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −4,000 | 22,000 | ||
| 2023-03-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Grant or award · Stock Options | +99,720 | 99,720 | ||
| 2023-03-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Grant or award · Restricted Stock Units | +15,592 | 15,592 | ||
| 2023-03-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Grant or award · Restricted Stock Units | +17,790 | 17,790 | ||
| 2023-03-15 | EDGEMOND JAMES CFO AND TREASURER | Grant or award · Stock Options | +58,170 | 58,170 |
Page 170 of 171 · 3,408 trades